|
ZNF441 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.910400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.762600E-01 |
| Normal-vs-Stage2 |
5.485800E-01 |
| Normal-vs-Stage3 |
7.629000E-04 |
| Normal-vs-Stage4 |
5.598300E-03 |
| Stage1-vs-Stage2 |
9.275800E-01 |
| Stage1-vs-Stage3 |
3.343100E-03 |
| Stage1-vs-Stage4 |
4.143800E-03 |
| Stage2-vs-Stage3 |
1.104230E-01 |
| Stage2-vs-Stage4 |
8.932100E-02 |
| Stage3-vs-Stage4 |
8.630800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.343440E-01 |
| Normal-vs-AfricanAmerican |
6.159800E-01 |
| Normal-vs-Asian |
1.012420E-01 |
| Caucasian-vs-AfricanAmerican |
4.341600E-01 |
| Caucasian-vs-Asian |
4.837200E-01 |
| AfricanAmerican-vs-Asian |
3.730200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.255810E-01 |
| Normal-vs-Female |
6.704400E-01 |
| Male-vs-Female |
3.156400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.818800E-01 |
| Normal-vs-Extreme_Weight |
1.331170E-01 |
| Normal-vs-Obese |
5.150800E-01 |
| Normal-vs-Extreme_Obese |
7.838500E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.241200E-01 |
| Normal_Weight-vs-Obese |
5.974400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.184600E-01 |
| Extreme_Weight-vs-Obese |
3.979000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.165400E-01 |
| Obese-vs-Extreme_Obese |
2.950600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.422200E-01 |
| Normal-vs-Age(41-60Yrs) |
9.852600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.008400E-02 |
| Normal-vs-Age(81-100Yrs) |
6.274000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.487200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.734200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.176600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.257800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.476830E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.213600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.895800E-01 |
| Normal-VS-Type2 PRCC |
1.44199999996264E-06 |
| Normal-VS-KIRP CIMP |
5.718000E-03 |
| Normal-VS-Unclassified PRCC |
7.026400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.04389996646859E-09 |
| Type1 PRCC-VS-KIRP CIMP |
2.063300E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
5.545600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.421800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.636400E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
2.072500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.524800E-03 |
| Normal-vs-N1 |
1.547960E-02 |
| Normal-vs-N2 |
4.359300E-03 |
| N0-vs-N1 |
9.843200E-01 |
| N0-vs-N2 |
9.132500E-02 |
| N1-vs-N2 |
9.459700E-02 |
|
|
